Literature DB >> 33393025

"Going Flat" After Mastectomy: Patient-Reported Outcomes by Online Survey.

Jennifer L Baker1, Don S Dizon2, Cachet M Wenziger3, Elani Streja3, Carlie K Thompson1, Minna K Lee1, Maggie L DiNome1, Deanna J Attai4,5.   

Abstract

BACKGROUND: The Going Flat movement aims to increase awareness and acceptance of mastectomy alone as a viable option for patients. Little is known about motivations and satisfaction with surgical outcomes in this population.
METHODS: An online survey was administered to 931 women who had a history of uni- or bilateral mastectomy for treatment of breast cancer or elevated breast cancer risk without current breast mound reconstruction. Satisfaction with outcome and surgeon support for the patient experience were characterized using 5-level scaled scores.
RESULTS: Mastectomy alone was the first choice for 73.7% of the respondents. The top two reasons for going flat were desire for a faster recovery and avoidance of a foreign body placement. Overall, the mean scaled satisfaction score was 3.72 ± 1.17 out of 5. In the multivariable analysis, low level of surgeon support for the decision to go flat was the strongest predictor of a satisfaction score lower than 3 (odds ratio [OR], 3.85; 95% confidence interval [CI], 2.59-5.72; p < 0.001). Dissatisfaction also was more likely among respondents reporting a body mass index (BMI) of 30 kg/m2 or higher (OR, 2.74; 95% CI, 1.76-4.27; p < 0.001) and those undergoing a unilateral procedure (OR, 1.99; 95% CI, 1.29-3.09; p = 0.002). Greater satisfaction was associated with receiving adequate information about surgical options (OR, 0.48; 95% CI, 0.32-0.69; p < 0.0001) and having a surgeon with a specialized breast surgery practice (OR, 0.56; 95% CI, 0.38-0.81; p = 0.002).
CONCLUSIONS: Most patients undergoing mastectomy alone are satisfied with their surgical outcome. Surgeons may optimize patient experience by recognizing and supporting a patient's decision to go flat.

Entities:  

Year:  2021        PMID: 33393025     DOI: 10.1245/s10434-020-09448-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  1 in total

1.  A social media survey of women who do not pursue reconstruction after mastectomy for breast cancer: Characterizing the "Going Flat" movement.

Authors:  Michelle E Wakeley; Colette F Bare; Rebecca Pine; Catherine Dube; Jennifer S Gass; Charu Taneja; Don S Dizon
Journal:  Breast J       Date:  2020-02-18       Impact factor: 2.431

  1 in total
  6 in total

1.  We Asked the Experts: One Size Does Not Fit All: The Option to Go Flat Following Mastectomy.

Authors:  Kari M Rosenkranz
Journal:  World J Surg       Date:  2021-08-20       Impact factor: 3.352

2.  Novel Patient-Reported Outcome Measures for the Assessment of Patient Satisfaction and Health-Related Quality of Life Following Postmastectomy Breast Reconstruction.

Authors:  Pavla Ticha; Meagan Wu; Michele Bujda; Andrej Sukop
Journal:  Aesthetic Plast Surg       Date:  2022-07-25       Impact factor: 2.708

3.  ASO Author Reflections: Perioperative Antibiotic Prophylaxis for Mastectomy-Too Much or Too Little.

Authors:  Russell Seth Martins; Abida K Sattar
Journal:  Ann Surg Oncol       Date:  2022-08-02       Impact factor: 4.339

4.  Not Just a Linear Closure: Aesthetic Flat Closure after Mastectomy.

Authors:  Kerry A Morrison; Nolan S Karp
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-05-18

5.  Patient preferences and comfort for cancer survivorship models of care: results of an online survey.

Authors:  Deanna J Attai; Matthew S Katz; Elani Streja; Jui-Ting Hsiung; Maria V Marroquin; Beverly A Zavaleta; Larissa Nekhlyudov
Journal:  J Cancer Surviv       Date:  2022-02-03       Impact factor: 4.442

6.  The double S technique to achieve aesthetic flat closure after conventional mastectomy.

Authors:  Daniel Steffens; Elisabeth A Kappos; Alexander Lunger; Fabienne D Schwab; Lea Zehnpfennig; Walter Paul Weber; Martin Haug; Viola Heinzelmann-Schwarz; Christian Kurzeder
Journal:  World J Surg Oncol       Date:  2022-02-21       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.